奥沙利铂
卡培他滨
医学
伊立替康
腹腔化疗
内科学
肿瘤科
癌症
结直肠癌
卵巢癌
作者
Niels A.D. Guchelaar,Marion W Tops-Welten,Pieter van der Sluis,Bo Jan Noordman,Stijn L.W. Koolen,Sjoerd M. Lagarde,Grard A. P. Nieuwenhuijzen,Micha J. de Neijs,Irene E G van Hellemond,Misha Luyer,Geert-Jan Creemers,Ignace H. J. T. de Hingh,Bianca Mostert,Bas P. L. Wijnhoven,Ron H.J. Mathijssen
标识
DOI：10.1016/j.biopha.2025.118491
摘要
Administration of 3-weekly CBIP irinotecan concomitant to systemic CAPOX was well tolerated at 75 mg in patients with gastric cancer and peritoneal metastases. Giving its promising clinical outcomes and the safety profile, CBIP of irinotecan provides a potential new treatment modality. A phase II study will commence to assess its feasibility and efficacy.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
嘻嘻哈哈
林狗
冷酷以山
快点毕业
整齐的孤菱
v0id
美好亦云
李杨
sadboy
七听
璐璐
YifanWang
你嵙这个期刊没买
平常迎天
Xixi
拉迪姆
GingerF
OK
忧心的曼凝
agathahqs
皖公网安备34019202002308
